Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Nexentis Technologies Inc. (NXTS)

0.5314 -0.0539 (-9.21%)
At close: November 2 at 4:00:00 PM EST
0.5355 +0.0041 (+0.77%)
After hours: 7:42:33 PM EST
Chart Range Bar
Loading chart for NXTS
Chart does not reflect overnight price.
  • Previous Close 0.5853
  • Open 0.5796
  • Bid 1.0100 x 200
  • Ask 0.6199 x 100
  • Day's Range 0.5100 - 0.5796
  • 52 Week Range 0.5050 - 24.1500
  • Volume 58,156
  • Avg. Volume 392,751
  • Market Cap (intraday) 1.262M
  • Beta (5Y Monthly) 1.98
  • PE Ratio (TTM) --
  • EPS (TTM) -21.5500
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

www.nexentistech.com

7

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NXTS
95.48%
S&P 500 (^GSPC)
10.17%

1-Year Return

NXTS
97.76%
S&P 500 (^GSPC)
10.25%

3-Year Return

NXTS
99.91%
S&P 500 (^GSPC)
74.66%

5-Year Return

NXTS
100.00%
S&P 500 (^GSPC)
62.86%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -29.54%

  • Return on Equity (ttm)

    -454.82%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -16.56M

  • Diluted EPS (ttm)

    -21.5500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.88M

  • Total Debt/Equity (mrq)

    23.91%

  • Levered Free Cash Flow (ttm)

    -5.48M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: